Straits Research released its highly anticipated report, “Global Nuclear Imaging Equipment Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 7.21 billion in 2025 and is anticipated to grow till USD 9.52 billion by 2034, growing at a CAGR of 3.18% from 2026-2034.
The nuclear imaging equipment market is driven by growing adoption of molecular imaging for early disease characterization, as clinicians increasingly rely on PET and SPECT systems to visualize metabolic shifts that are undetectable on anatomical imaging alone. However, market expansion is restrained by the limited availability of radiotracer production infrastructure in regions without dedicated radiopharmacy networks, which places operational constraints on facilities seeking to broaden their nuclear imaging services. Despite these challenges, the market presents a strong opportunity through the rapid advancement of targeted radioligand therapies, as clinical trials and treatment programs require high-precision imaging systems for patient selection, treatment planning, and therapeutic monitoring, creating new demand across hospitals and research institutions worldwide.
July 2024: Shanghai United Imaging Healthcare Co., Ltd. announced that it had installed the first PET/CT scanner in Mexico, located at the Instituto Nacional de Pediatría.